相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Alpha-1 Adrenergic Receptors are Localized on Presynaptic Elements in the Nucleus Accumbens and Regulate Mesolimbic Dopamine Transmission
Darlene A. Mitrano et al.
NEUROPSYCHOPHARMACOLOGY (2012)
ACTIVATION OF ALPHA1-ADRENOCEPTORS ENHANCES GLUTAMATE RELEASE ONTO VENTRAL TEGMENTAL AREA DOPAMINE CELLS
M. C. Velasquez-Martinez et al.
NEUROSCIENCE (2012)
Disulfiram stimulates dopamine release from noradrenergic terminals and potentiates cocaine-induced dopamine release in the prefrontal cortex
Paola Devoto et al.
PSYCHOPHARMACOLOGY (2012)
α2 Adrenergic and Imidazoline Receptor Agonists Prevent Cue-Induced Cocaine Seeking
Rachel J. Smith et al.
BIOLOGICAL PSYCHIATRY (2011)
Randomized, double blind, placebo-controlled trial of disulfiram for the treatment of cocaine dependence in methadone-stabilized patients
Alison Oliveto et al.
DRUG AND ALCOHOL DEPENDENCE (2011)
PROPENSITY TO 'RELAPSE' FOLLOWING EXPOSURE TO COCAINE CUES IS ASSOCIATED WITH THE RECRUITMENT OF SPECIFIC THALAMIC AND EPITHALAMIC NUCLEI
M. H. James et al.
NEUROSCIENCE (2011)
Structural Insight of Dopamine β-Hydroxylase, a Drug Target for Complex Traits, and Functional Significance of Exonic Single Nucleotide Polymorphisms
Abhijeet Kapoor et al.
PLOS ONE (2011)
Clonidine blocks stress-induced craving in cocaine users
Michelle L. Jobes et al.
PSYCHOPHARMACOLOGY (2011)
Disulfiram Attenuates Drug-Primed Reinstatement of Cocaine Seeking via Inhibition of Dopamine β-Hydroxylase
Jason P. Schroeder et al.
NEUROPSYCHOPHARMACOLOGY (2010)
Mechanisms of Disulfiram-induced Cocaine Abstinence: Antabuse and Cocaine Relapse
Meriem Gaval-Cruz et al.
MOLECULAR INTERVENTIONS (2009)
Ventral tegmental glutamate: A role in stress-, cue-, and cocaine-induced reinstatement of cocaine-seeking
Roy A. Wise
NEUROPHARMACOLOGY (2009)
Anti-relapse medications: Preclinical models for drug addiction treatment
Noushin Yahyavi-Firouz-Abadi et al.
PHARMACOLOGY & THERAPEUTICS (2009)
Interaction between noradrenaline and corticotrophin-releasing factor in the reinstatement of cocaine seeking in the rat
Zenya J. Brown et al.
PSYCHOPHARMACOLOGY (2009)
alpha(1)-Noradrenergic system role in increased motivation for cocaine intake in rats with prolonged access
Sunmee Wee et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2008)
Genetic or pharmacological blockade of noradrenaline synthesis enhances the neurochemical, behavioral, and neurotoxic effects of methamphetamine
David Weinshenker et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Infralimbic prefrontal cortex is responsible for inhibiting cocaine seeking in extinguished rats
Jamie Peters et al.
JOURNAL OF NEUROSCIENCE (2008)
There and back again: A tale of norepinephrine and drug addiction
David Weinshenker et al.
NEUROPSYCHOPHARMACOLOGY (2007)
Previous exposure to cocaine enhances cocaine self-administration in an alpha 1-adrenergic receptor dependent manner
Xiang-Yang Zhang et al.
NEUROPSYCHOPHARMACOLOGY (2007)
Imaging stress- and cue-induced drug and alcohol craving: association with relapse and clinical implications
Rajita Sinha et al.
DRUG AND ALCOHOL REVIEW (2007)
Systemic administration of a dopamine, but not a serotonin or norepinephrine, transporter inhibitor reinstates cocaine seeking in the rat
Heath D. Schmidt et al.
BEHAVIOURAL BRAIN RESEARCH (2006)
Neural substrates of cocaine-cue associations that trigger relapse
RE See
EUROPEAN JOURNAL OF PHARMACOLOGY (2005)
Prazosin, an α-1 adrenergic antagonist, reduces cocaine-induced reinstatement of drug-seeking
XY Zhang et al.
BIOLOGICAL PSYCHIATRY (2005)
The role of prefrontal cortex D1-like and D2-like receptors in cocaine-seeking behavior in rats
WL Sun et al.
PSYCHOPHARMACOLOGY (2005)
Efficacy of disulfiram and cognitive behavior therapy in cocaine-dependent outpatients - A randomized placebo-controlled trial
KM Carroll et al.
ARCHIVES OF GENERAL PSYCHIATRY (2004)
The reinstatement model of drug relapse: history, methodology and major findings
Y Shaham et al.
PSYCHOPHARMACOLOGY (2003)
Alpha-2 adrenergic receptor agonists block stress-induced reinstatement of cocaine seeking
S Erb et al.
NEUROPSYCHOPHARMACOLOGY (2000)